
An Ebola outbreak in the Democratic Republic of Congo has killed more than 5,300 people. The Bundibugyo strain has spread to Kenya and Uganda, while suspected cases in Nigeria tested negative.
7:50 PMAl Jazeera23 stories from 7 sources
Supporting Articles

An Ebola outbreak in the Democratic Republic of Congo has killed more than 5,300 people. The Bundibugyo strain has spread to Kenya and Uganda, while suspected cases in Nigeria tested negative.
7:50 PMAl Jazeera
A child in Lewis County has died from measles, marking New York State’s first fatality from the disease in three decades. Gov. Kathy Hochul attributed the outbreak to declining vaccination levels.
10:58 PMNYT New York
A Washington state resident died from complications of bird flu after exposure to infected cattle. The death is the first reported U.S. bird flu death in a year.
3:44 PMStat News
Leaders of NYC Health + Hospitals warn that federal health policy changes could strip Medicaid coverage from hundreds of thousands of New Yorkers. They expect the losses to increase pressure on the city's public hospital system.
4:45 PMThe City
The FDA approved a generic HIV prevention injection, clearing a major regulatory hurdle for expanded access in dozens of lower-income countries.
11:13 AMStat News
Researchers found that an experimental drug originally developed for spinal cord injuries reduced DNA damage and inflammation, two processes linked to Alzheimer’s disease. The treatment has already undergone initial human safety testing, which could accelerate its development for Alzheimer’s.
11:11 PMScienceDaily
Summary
An Ebola outbreak in the Democratic Republic of Congo has killed more than 5,300 people. The Bundibugyo strain has spread to Kenya and Uganda, while suspected cases in Nigeria tested negative.
The spread beyond Congo raises the risk of a wider regional outbreak and complicates containment
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Cross-border transmission could rapidly expand the outbreak’s geographic and humanitarian impact.

Summary
A child in Lewis County has died from measles, marking New York State’s first fatality from the disease in three decades. Gov. Kathy Hochul attributed the outbreak to declining vaccination levels.
The death turns New York’s measles outbreak from a public health warning into a confirmed
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A preventable child death shows how declining vaccination coverage is allowing measles to regain deadly consequences in New York.

Summary
A Washington state resident died from complications of bird flu after exposure to infected cattle. The death is the first reported U.S. bird flu death in a year.
The death confirms that cattle-associated bird flu infections can still produce severe human outcomes, even
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The case keeps occupational exposure to infected cattle at the center of U.S. bird flu surveillance and prevention efforts.

Summary
Leaders of NYC Health + Hospitals warn that federal health policy changes could strip Medicaid coverage from hundreds of thousands of New Yorkers. They expect the losses to increase pressure on the city's public hospital system.
The immediate change is a projected coverage loss that would shift more uninsured patients onto
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Medicaid restrictions could turn a federal coverage change into a direct crisis for New York's safety-net hospitals.

Summary
The FDA approved a generic HIV prevention injection, clearing a major regulatory hurdle for expanded access in dozens of lower-income countries.
Generic approval should increase the potential supply of long-acting prevention and reduce reliance on a
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A lower-cost preventive option could extend HIV protection to populations poorly served by daily pills or expensive branded medicines.

Summary
Researchers found that an experimental drug originally developed for spinal cord injuries reduced DNA damage and inflammation, two processes linked to Alzheimer’s disease. The treatment has already undergone initial human safety testing, which could accelerate its development for Alzheimer’s.
The key shift is that one existing drug candidate may address multiple underlying mechanisms rather
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A drug with prior human safety testing could make it faster and less costly to test a disease-modifying Alzheimer’s treatment.
A curated list of other prominent stories from this day.

Researchers found that an experimental drug rejuvenated aging liver cells in rats, halved levels of a protein associated with Alzheimer’s disease, and restored youthful cholesterol levels. The treatment also revived a liver communication system that helps remove harmful substances from the bloodstream.
7:34 PMScienceDaily
Vera Health raised $28.5 million in Series A funding, bringing its total financing to $32 million. Its AI-powered app gives clinicians answers by searching a broad body of medical information, and the new capital will fund expansion.
2:49 PMPYMNTS
Health care affordability is emerging as a major voter concern, while a new type of medical clinic is leaving some patients with large bills by billing urgent care visits as emergency department care.
12:05 PMStat News
Five Bay Area laboratories collaborated to test whether psilocybin produces lasting changes in anxiety- and depression-like behavior in mice. The results showed limited evidence of durable benefits.
11:47 AMStat News
Renewed fighting between Tigrayan rebels and Ethiopia’s government has broken the 2022 peace deal and pushed health services in the north toward collapse.
11:03 AMAl Jazeera
A 24-year study of more than 8,200 adults found that excess body weight was associated with faster declines in memory, concentration, and decision-making. The relationship was strongest among adults over 65, suggesting that obesity may compound age-related brain deterioration.
8:55 AMScienceDaily
Researchers argue that hypertension guidance should focus not only on reducing sodium but also on increasing dietary potassium. The report says the combination may lower blood pressure more effectively than sodium restriction alone.
8:10 AMScienceDaily
The piece examines the global fertility industry surrounding MRT and the women who undergo the treatment while it remains experimental. It presents the treatment through the risks and ethical concerns raised by reporting from inside that market.
8:08 AMStat News
Researchers developed an implant that uses an electrically powered catalyst to convert excess glucose into a substance eliminated in urine, without insulin or conventional glucose-lowering drugs. The device lowered blood sugar and promoted weight loss in diabetic mice.
7:47 AMScienceDaily
In mice, certain obesity-associated diets made cancer immunotherapy more effective. The researchers linked the effect to interactions between food and gut bacteria that strengthened the immune response against tumors.
7:13 AMScienceDaily
New York has reported more than 10,000 flu cases, with infections rising rapidly among children. Public health experts are urging residents to get vaccinated now.
6:56 AMNYT New York
Kings County Hospital nurse practitioner Sarah Dowd was ordered back to work after a three-week suspension. She and her union say the suspension was retaliation for organizing, while the hospital system appears to have paused its misconduct investigation.
5:01 AMThe City
A mitochondrial replacement technique developed to reduce the risk of inherited mitochondrial disease is being marketed to older women as a fertility treatment despite limited evidence that it works for that purpose.
4:30 AMStat News
Paul Markovich, president and CEO of Ascendiun, argues that the financial structure of U.S. health care is failing patients, providers, and the organizations that pay for care.
4:30 AMStat News
A maternal-fetal medicine specialist argues that many pregnant patients can receive safe cancer treatment without ending their pregnancies.
4:30 AMStat News
Investors and physicians are awaiting mid-stage results for an experimental Kymera therapy aimed at treating eczema and competing with Dupixent.
4:30 AMStat News
Amgen’s effort to compete in the obesity-drug market traces back to genetic research developed at the University of Iceland Science Park in Reykjavík. The work began with biological samples stored in a basement freezer and now informs the company’s search for a blockbuster treatment.
12:00 AMBloomberg Markets
Summary
Researchers found that an experimental drug rejuvenated aging liver cells in rats, halved levels of a protein associated with Alzheimer’s disease, and restored youthful cholesterol levels. The treatment also revived a liver communication system that helps remove harmful substances from the bloodstream.
The important shift is the possibility that liver aging contributes to disease processes typically studied
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If the liver helps drive systemic aging, therapies aimed outside the brain could eventually become part of Alzheimer’s prevention.

Summary
Vera Health raised $28.5 million in Series A funding, bringing its total financing to $32 million. Its AI-powered app gives clinicians answers by searching a broad body of medical information, and the new capital will fund expansion.
The financing moves Vera from product development toward wider clinical adoption. Its growth will depend
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
AI tools that reduce clinical research time could gain traction, but healthcare buyers will demand stronger evidence and safeguards than consumer software markets.

Summary
Health care affordability is emerging as a major voter concern, while a new type of medical clinic is leaving some patients with large bills by billing urgent care visits as emergency department care.
Affordability is becoming both a political liability and a pricing problem for patients who cannot
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Unexpected facility fees can turn routine care into significant debt and give health costs greater influence over midterm voting.

Summary
Five Bay Area laboratories collaborated to test whether psilocybin produces lasting changes in anxiety- and depression-like behavior in mice. The results showed limited evidence of durable benefits.
The findings weaken claims that psilocybin reliably produces long-term effects, at least in this preclinical
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Limited and inconsistent durability signals could slow clinical enthusiasm and redirect research toward dose, timing, and patient-selection questions.

Summary
Renewed fighting between Tigrayan rebels and Ethiopia’s government has broken the 2022 peace deal and pushed health services in the north toward collapse.
The return of fighting is reversing the fragile gains made since the peace agreement and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A collapsing health system could turn renewed conflict into a wider crisis of preventable deaths, displacement, and disease.

Summary
A 24-year study of more than 8,200 adults found that excess body weight was associated with faster declines in memory, concentration, and decision-making. The relationship was strongest among adults over 65, suggesting that obesity may compound age-related brain deterioration.
The decisive finding is the long-term link between higher body weight and faster cognitive decline,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Reducing obesity may offer a practical way to lower cognitive-health risks as populations age.

Summary
Researchers argue that hypertension guidance should focus not only on reducing sodium but also on increasing dietary potassium. The report says the combination may lower blood pressure more effectively than sodium restriction alone.
The proposed shift would broaden hypertension prevention from limiting a harmful nutrient to improving the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A stronger focus on potassium could improve blood pressure control, but implementation must avoid exposing vulnerable patients to electrolyte risks.

Summary
The piece examines the global fertility industry surrounding MRT and the women who undergo the treatment while it remains experimental. It presents the treatment through the risks and ethical concerns raised by reporting from inside that market.
The decisive issue is the gap between commercial access and reliable evidence. Women may bear
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The story raises the need for stronger oversight before experimental fertility treatments become normalized through private markets.

Summary
Researchers developed an implant that uses an electrically powered catalyst to convert excess glucose into a substance eliminated in urine, without insulin or conventional glucose-lowering drugs. The device lowered blood sugar and promoted weight loss in diabetic mice.
The result is an early proof of concept, not a demonstrated treatment for people with
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The device points to a non-drug strategy for diabetes, but its clinical value remains untested beyond animal models.

Summary
In mice, certain obesity-associated diets made cancer immunotherapy more effective. The researchers linked the effect to interactions between food and gut bacteria that strengthened the immune response against tumors.
The finding challenges the assumption that healthier diets will always produce the strongest treatment response,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Personalized nutrition could become part of cancer treatment, but translating this counterintuitive result without increasing obesity-related harm will be difficult.

Summary
New York has reported more than 10,000 flu cases, with infections rising rapidly among children. Public health experts are urging residents to get vaccinated now.
The early surge is putting children at the center of New York's flu season and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
An early pediatric surge could quickly increase school absences and pressure on medical care.

Summary
Kings County Hospital nurse practitioner Sarah Dowd was ordered back to work after a three-week suspension. She and her union say the suspension was retaliation for organizing, while the hospital system appears to have paused its misconduct investigation.
Ordering Dowd back while halting the investigation reduces the immediate punishment but leaves the central
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The handling of one nurse's suspension could shape labor relations and workers' willingness to organize across the city hospital system.

Summary
A mitochondrial replacement technique developed to reduce the risk of inherited mitochondrial disease is being marketed to older women as a fertility treatment despite limited evidence that it works for that purpose.
The core problem is a gap between the procedure’s established rationale and the claims made
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The case exposes how experimental reproductive technologies can reach patients before evidence supports the benefits being advertised.

Summary
Paul Markovich, president and CEO of Ascendiun, argues that the financial structure of U.S. health care is failing patients, providers, and the organizations that pay for care.
The argument treats rising costs and distorted incentives as structural problems rather than isolated failures
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Cost growth and misaligned incentives directly shape affordability, access, and the quality of care Americans receive.

Summary
A maternal-fetal medicine specialist argues that many pregnant patients can receive safe cancer treatment without ending their pregnancies.
The central shift is clinical and ethical: pregnancy should not automatically be treated as incompatible
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The issue affects whether pregnant cancer patients receive informed choices or are pushed toward termination without a full assessment of available treatments.

Summary
Investors and physicians are awaiting mid-stage results for an experimental Kymera therapy aimed at treating eczema and competing with Dupixent.
The trial readout will determine whether Kymera has a credible path into a market dominated
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The results could reshape expectations for the next generation of eczema treatments and Kymera’s value as a drug developer.

Summary
Amgen’s effort to compete in the obesity-drug market traces back to genetic research developed at the University of Iceland Science Park in Reykjavík. The work began with biological samples stored in a basement freezer and now informs the company’s search for a blockbuster treatment.
Amgen is turning Icelandic genetic data into a potential advantage in the race for the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The episode shows how population-level genetic research is becoming a strategic asset in the fast-growing obesity-drug market.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!